Literature DB >> 2209666

Peroxisomal beta-oxidation defect with detectable peroxisomes: a case with neonatal onset and progressive course.

P G Barth1, R J Wanders, R B Schutgens, E M Bleeker-Wagemakers, D van Heemstra.   

Abstract

A progressive demyelinating cerebral disorder is described in a normally-appearing female infant with neonatal seizures, progressive psychomotor deterioration, deafness, retinopathy, peripheral neuropathy and loss of myelin observed on magnetic resonance imaging (MRI) scanning. MRI also showed the absence of macroscopic neocortical dysplasia which is usually found in Zellweger syndrome (ZS). Adrenal cortical function was normal. The patient died at the age of 37 months. Extensive biochemical investigations of peroxisomal functions in the patient revealed an impairment of peroxisomal beta-oxidation resulting in elevated levels of very long (greater than C22) chain fatty acids in plasma and fibroblasts. Moreover, elevated plasma levels of intermediates of bile acid biosynthesis such as tri- and dihydroxycholestanoic acid were found. Other peroxisomal functions were normal. Immunoblotting of the peroxisomal beta-oxidation enzyme proteins in liver from the patient revealed normal responses with antisera against acyl-CoA oxidase, bifunctional protein and thiolase respectively. From these data we conclude that the patient had a deficiency of a single peroxisomal beta-oxidation enzyme at the level of either the bifunctional protein or peroxisomal thiolase with retained immunoreactivity against these enzymes.

Entities:  

Mesh:

Year:  1990        PMID: 2209666     DOI: 10.1007/bf01959531

Source DB:  PubMed          Journal:  Eur J Pediatr        ISSN: 0340-6199            Impact factor:   3.183


  36 in total

1.  Neuropathological considerations in cerebro-hepato-renal syndrome (Zellweger's syndrome).

Authors:  H M Liu; B S Bangaru; J Kidd; J Boggs
Journal:  Acta Neuropathol       Date:  1976-03-15       Impact factor: 17.088

2.  Dietary effects on serum-phytanic-acid levels and on clinical manifestations in heredopathia atactica polyneuritiformis.

Authors:  L Eldjarn; K Try; O Stokke; A W Munthe-Kaas; S Refsum; D Steinberg; J Avigan; C Mize
Journal:  Lancet       Date:  1966-03-26       Impact factor: 79.321

3.  Neonatal adrenoleukodystrophy: clinical, pathologic, and biochemical delineation of a syndrome affecting both males and females.

Authors:  R Jaffe; P Crumrine; Y Hashida; H W Moser
Journal:  Am J Pathol       Date:  1982-07       Impact factor: 4.307

4.  Lignoceroyl-CoASH ligase: enzyme defect in fatty acid beta-oxidation system in X-linked childhood adrenoleukodystrophy.

Authors:  M Hashmi; W Stanley; I Singh
Journal:  FEBS Lett       Date:  1986-02-17       Impact factor: 4.124

5.  New phenotypic variant of adrenoleukodystrophy. Pathologic, ultrastructural, and biochemical study in two brothers.

Authors:  H J Manz; M Schuelein; D C McCullough; Y Kishimoto; R M Eiben
Journal:  J Neurol Sci       Date:  1980-03       Impact factor: 3.181

6.  Cerebro-hepato-renal syndrome. Report of a case with histochemical and ultrastructural observations.

Authors:  D P Agamanolis; H B Robinson; G D Timmons
Journal:  J Neuropathol Exp Neurol       Date:  1976-05       Impact factor: 3.685

7.  Peroxisomal bifunctional enzyme deficiency.

Authors:  P A Watkins; W W Chen; C J Harris; G Hoefler; S Hoefler; D C Blake; A Balfe; R I Kelley; A B Moser; M E Beard
Journal:  J Clin Invest       Date:  1989-03       Impact factor: 14.808

8.  Molecular analysis of peroxisomal beta-oxidation enzymes in infants with Zellweger syndrome and Zellweger-like syndrome: further heterogeneity of the peroxisomal disorder.

Authors:  Y Suzuki; N Shimozawa; T Orii; N Igarashi; N Kono; T Hashimoto
Journal:  Clin Chim Acta       Date:  1988-02-29       Impact factor: 3.786

9.  Globoid cells, glial nodules, and peculiar fibrillary changes in the cerebro-hepato-renal syndrome of Zellweger.

Authors:  G A de León; W D Grover; D S Huff; G Morinigo-Mestre; H H Punnett; M L Kistenmacher
Journal:  Ann Neurol       Date:  1977-12       Impact factor: 10.422

10.  Neonatal seizures and retardation in a girl with biochemical features of X-linked adrenoleukodystrophy: a possible new peroxisomal disease entity.

Authors:  S Naidu; G Hoefler; P A Watkins; W W Chen; A B Moser; S Hoefler; N E Rance; J M Powers; M Beard; W R Green
Journal:  Neurology       Date:  1988-07       Impact factor: 9.910

View more
  10 in total

1.  Bifunctional enzyme deficiency: identification of a new type of peroxisomal disorder in a patient with an impairment in peroxisomal beta-oxidation of unknown aetiology by means of complementation analysis.

Authors:  R J Wanders; C W van Roermund; S Brul; R B Schutgens; J M Tager
Journal:  J Inherit Metab Dis       Date:  1992       Impact factor: 4.982

2.  Zellweger-like phenotype in two siblings: a defect in peroxisomal beta-oxidation with elevated very long-chain fatty acids but normal bile acids.

Authors:  H Mandel; M Berant; A Aizin; R Gershony; S Hemmli; R B Schutgens; R J Wanders
Journal:  J Inherit Metab Dis       Date:  1992       Impact factor: 4.982

3.  Measurement of dihydroxyacetone-phosphate acyltransferase (DHAPAT) in chorionic villous samples, blood cells and cultured cells.

Authors:  R J Wanders; R Ofman; G J Romeijn; R B Schutgens; P A Mooijer; C Dekker; H van den Bosch
Journal:  J Inherit Metab Dis       Date:  1995       Impact factor: 4.982

4.  Measurement of peroxisomal fatty acid beta-oxidation in cultured human skin fibroblasts.

Authors:  R J Wanders; S Denis; J P Ruiter; R B Schutgens; C W van Roermund; B S Jacobs
Journal:  J Inherit Metab Dis       Date:  1995       Impact factor: 4.982

5.  Amino acid and nucleotide sequences of human peroxisomal enoyl-CoA hydratase: 3-hydroxyacyl-CoA dehydrogenase cDNA.

Authors:  S Fukuda; Y Suzuki; N Shimozawa; Z Zhang; T Orii; T Aoyama; T Hashimoto; N Kondo
Journal:  J Inherit Metab Dis       Date:  1998-02       Impact factor: 4.982

6.  Isolated defect of peroxisomal beta-oxidation in a 16-year-old patient.

Authors:  R Santer; A Claviez; H D Oldigs; J Schaub; R B Schutgens; R J Wanders
Journal:  Eur J Pediatr       Date:  1993-04       Impact factor: 3.183

7.  Novel subtype of peroxisomal acyl-CoA oxidase deficiency and bifunctional enzyme deficiency with detectable enzyme protein: identification by means of complementation analysis.

Authors:  Y Suzuki; N Shimozawa; S Yajima; S Tomatsu; N Kondo; Y Nakada; S Akaboshi; M Lai; Y Tanabe; T Hashimoto
Journal:  Am J Hum Genet       Date:  1994-01       Impact factor: 11.025

8.  Peroxisomal localization of the immunoreactive beta-oxidation enzymes in a neonate with a beta-oxidation defect. Pathological observations in liver, adrenal cortex and kidney.

Authors:  M Espeel; F Roels; L Van Maldergem; D De Craemer; G Dacremont; R J Wanders; T Hashimoto
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1991

9.  Oxidation of pristanic acid in fibroblasts and its application to the diagnosis of peroxisomal beta-oxidation defects.

Authors:  B C Paton; P C Sharp; D I Crane; A Poulos
Journal:  J Clin Invest       Date:  1996-02-01       Impact factor: 14.808

Review 10.  Inborn errors of bile acid metabolism.

Authors:  P T Clayton
Journal:  J Inherit Metab Dis       Date:  1991       Impact factor: 4.982

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.